#Anvisa incentiva viablização de #genéricos mais rápida

A Anvisa está estimulando o acesso mais rápido à medicamentos genéricos através de uma consulta pública que visa tornar obrigatória a venda de amostras de medicamentos restritos a centros de pesquisa de genéricos. Dentre estes medicamentos estão antibióticos, antirretrovirais e drogas contra o câncer. O Diretor-Presidente da Anvisa, Dirceu Barbano, alerta que isso ajudará a trazer ao mercado, por exemplo, …

Video: #OrphanDrug landscape in Japan

Nobuo Uemura, International Liaison Officer at the Pharmaceuticals and Medical Devices Agency of Japan, presented at last year's World Orphan Drug Congress USA on the topic ‘Orphan drug landscape in Japan.' Do you want to learn more about: Promoting orphan drug/device development Regulatory framework Recent activity to promote orphan drug development in the country If so, you need to check …

Video: US FDA on strategies to address unmet #RareDisease patient needs

Dr. Timothy Cote, Director of the Office of Orphan Product Development at the US FDA, presented at last year's World Orphan Drug Congress USA on the topic ‘Building an integrated, comprehensive and long-term strategy to address unmet patient needs in the US.' Do you want to learn more about: Incentives to make orphan diseases a national priority Brownback/Brown Amendment status …

Video: Kakkis Every Life Foundation on accelerating biotechnology for #RareDisease

Emil Kakkis, President of the Kakkis Every Life Foundation, presented at last year's World Orphan Drug Congress USA on the topic ‘Next steps in accelerating biotechnology for rare diseases.' Do you want to learn more about: Improving access to the accelerated approval pathway thru science-driven regulatory reform Helping patients get earlier access to specific, effective treatment Developing appropriate surrogate markers …

Increased fragmentation in Asia’s pharmaceutical markets?

FOR IMMEDIATE RELEASE Asia will continue to grow in importance for the pharmaceutical industry because of two well known reasons: The continent claims 60% of the world's population and a growing affluent income group with increasing medical needs. Also Asian countries offer lower costs across manufacturing, R&D and clinical trials. Increasing investments by global and Asian pharmas provide ample evidence …

Less than 30 complimentary seats left for technology showcase seminars at BioPharma Asia Convention!

More than 20 solution providers across the biopharmaceutical industry are showcasing their latest technologies and innovations at BioPharma Asia Convention 2012. Leverage on these sessions to identify business development and investment opportunities in the emerging markets of Asia. Simply learn from the best in the industry and foster new business relations with industry experts. Attend the technology showcase to: Grow …

William Chen Wei Ning on Pharmacogenetics and Pharmacoproteomics Analysis of Patients on Warfarin Anticoagulant Therapy: identification of potential biomarker

Professor William Chen Wei Ning, Professor at School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore will be presenting at BioPharma Asia Convention‘s on floor seminar on 21 March 2012 at 1.30pm on Pharmacogenetics and Pharmacoproteomics Analysis of Patients on Warfarin Anticoagulant Therapy: identification of potential biomarker. As a scholar, he received his Bachelor and PhD degrees in Molecular …

Li Peng on Broad-spectrum antimicrobial polymers and coatings

Li Peng would be representing Prof Mary B Chan-Park, Acting Chair, School of Chemical & Biomedical Engineering, Nanyang Technological University to speak at the on floor seminars at BioPharma Asia Convention 2012 at the Research Institute Showcase on 21 March 2012 at 2.00pm. The following would be a summary of what he would be presenting: Modern medical implants such as …